✦ LIBER ✦

Phase II study of the eortc breast group with vorozole (R 83842), a new non-steroidal aromatase inhibitor in metastatic breast cancer (MBC) — preliminary results

✍ Scribed by Paridaens, R.; Piccart, M.; Nooy, M.; Klijn, J.G.M.; Rubens, R.D.; Beex, L.; Tomiak, E.; Van Vreckem, A.; Vinholes, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy with estrogenic recruitment

✍ R. Paridaens; J.Blonk van der Wijst; J.P. Julien; E. Ferrazzi; A. Clarysse; J.C. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Phase II study with dose finding of Oral

✍ F. Nolè; Catania; G. Sanna; R. Mattioli; D. Crivellari; P. Foa; G. Pinotti; D. L 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Is the response duration to aromatase in

✍ I Glogowska; R Sienkiewicz-Kozlowska; T Pienkowski; S Jaczewska; A Jagiello-Grus 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB

579 Chemotherapy with estrogenic recruit

✍ R. Paridaens; J.Blonk van der Wijst; J.P. Julien; E. Ferrazzi; A. Clarysse; J.C. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 133 KB

First results of a randomized phase III

✍ R Paridaens; P Therasse; L Dirix; L Beex; M.J Piccart; D Cameron; T Cufer; K Roo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB